5-135535554-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006161.3(NEUROG1):c.137C>A(p.Ala46Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000704 in 1,420,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006161.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEUROG1 | NM_006161.3 | c.137C>A | p.Ala46Glu | missense_variant | 1/1 | ENST00000314744.6 | NP_006152.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEUROG1 | ENST00000314744.6 | c.137C>A | p.Ala46Glu | missense_variant | 1/1 | 6 | NM_006161.3 | ENSP00000317580.4 | ||
ENSG00000250167 | ENST00000698884.1 | n.496+48785G>T | intron_variant | |||||||
SLC25A48 | ENST00000698885.1 | n.364+25798G>T | intron_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000223 AC: 4AN: 179524Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 99550
GnomAD4 exome AF: 0.00000704 AC: 10AN: 1420324Hom.: 0 Cov.: 31 AF XY: 0.00000426 AC XY: 3AN XY: 704484
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.137C>A (p.A46E) alteration is located in exon 1 (coding exon 1) of the NEUROG1 gene. This alteration results from a C to A substitution at nucleotide position 137, causing the alanine (A) at amino acid position 46 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at